{"id":"CHEMBL1047","canonicalSmiles":"CC(=O)Oc1c(C)c(C)c2c(c1C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"ZAKOWWREFLAJOT-CEFNRUSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCOPHEROL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205044","144205117","144207016","144213754","170465444","29218011","57264399"],"Wikipedia":["Tocopheryl_acetate"],"drugbank":["DB14002"],"chEBI":["32321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OIRDTQYFTABQOQ-UHTZMRCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIDARABINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vira-a"],"synonyms":["ARA-A","Arabinosyladenine","Arasena-a","CI 673","CI-673","NSC-247519","NSC-404241","NSC-757383","Vidarabine","Vidarabine anhydrous","Vidarabine monohydrate","Vidarabine, anhydrous"],"crossReferences":{"PubChem":["11112564","47193870"],"Wikipedia":["Vidarabine"],"drugbank":["DB00194"],"chEBI":["45327"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for viral disease and eye infection and has 1 investigational indication."}
{"id":"CHEMBL1096","canonicalSmiles":"CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1","inchiKey":"SGRYPYWGNKJSDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMLEXANOX","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amlexanox","Aphthasol"],"synonyms":["AA-673","Amlexanox","Amoxanox","Aphtheal","CHX 3673","CHX-3673","Elics","Solfa"],"crossReferences":{"PubChem":["124893315","144206029","170465365","26719859","50112726"],"Wikipedia":["Amlexanox"],"drugbank":["DB01025"],"chEBI":["31205"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["HP_0006536","EFO_1001904"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for airway obstruction and has 1 investigational indication."}
{"id":"CHEMBL1097615","canonicalSmiles":"CC#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]c1=O","inchiKey":"QLOCVMVCRJOTTM-SDNRWEOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETIVUDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["882C-87","882C87","Netivudine"],"crossReferences":{"drugbank":["DB12606"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1160819","canonicalSmiles":"N","inchiKey":"QGZKDVFQNNGYKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIA SOLUTION, STRONG","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ammonia","Ammonia gas","Ammonia solution","Ammonia solution, strong","Ammonia spirit, aromatic","Ammonia water","Ammonia,aromatic","Ammonia-solution","Ammonium causticum","Ammonium hydroxide","Ammonium water","Aqua ammonia","Aqueous ammonia","E-527","INS NO.527","INS-527","Nitro-sil","R 717 (ammonia)","Refrigerent r717","Spirit of hartshorn","Strong ammonia solution","Strong-ammonia solution"],"crossReferences":{"DailyMed":["ammonia%20n-13"],"Wikipedia":["Ammonia"],"chEBI":["16134"]},"childChemblIds":["CHEMBL1201189"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007 and is indicated for coronary artery disease."}
{"id":"CHEMBL1199540","canonicalSmiles":"O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"LVASCWIMLIKXLA-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Halofuginone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halofuginone"],"crossReferences":{"Wikipedia":["Halofuginone"],"drugbank":["DB04866"]},"childChemblIds":["CHEMBL1162015"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200382","canonicalSmiles":"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1.Cl.O","inchiKey":"UEECHQPWQHYEDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPRIDIL HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1008","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepadin","Vascor"],"synonyms":["Bepridil hydrochloride","Bepridil hydrochloride hydrate","CERM 1978","CERM-1978","Cordium","NSC-758390","Unicordium"],"crossReferences":{"chEBI":["52715"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200555","canonicalSmiles":"CN(C(=O)CC(=O)N(C)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I","inchiKey":"XUHXFSYUBXNTHU-UHFFFAOYSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"IOTROLAN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Osmovist","Osmovist 190","Osmovist 240"],"synonyms":["Iotrol","Iotrolan","Isovist 300","ZK 39 482","ZK-39-482","ZK-39482"],"crossReferences":{"Wikipedia":["Iotrolan"],"drugbank":["DB09487"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200625","canonicalSmiles":"[89Sr+2].[Cl-].[Cl-]","inchiKey":"AHBGXTDRMVNFER-FCHARDOESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM CHLORIDE SR 89","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219640","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metastron","Strontium chloride sr-89"],"synonyms":["89sr","SMS-2PA","SMS2PA","Strontium (89 sr) chloride","Strontium (89Sr) Chloride","Strontium (89sr) chloride","Strontium 89 chloride","Strontium chloride sr 89","Strontium chloride sr-89","Strontium chloride, sr-89","Strontium-89 chloride"],"crossReferences":{"DailyMed":["strontium%20chloride%20sr-89"],"drugbank":["DB09498"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for metastasis and has 1 investigational indication."}
{"id":"CHEMBL1200670","canonicalSmiles":"CC(=O)O.CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C.O","inchiKey":"YBZYNINTWCLDQA-UHKVWXOHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SARALASIN ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL938","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sarenin"],"synonyms":["P-113","Saralasin acetate","Saralasin hydrated acetate"],"crossReferences":{"Wikipedia":["Saralasin"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200794","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl","inchiKey":"BCGJBQBWUGVESK-KCTCKCTRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYMORPHONE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL963","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Numorphan","Opana","Opana er","Oxymorphone hydrochloride"],"synonyms":["Oxymorphone hcl","Oxymorphone hydrochloride"],"crossReferences":{"DailyMed":["oxymorphone%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","EFO_0003843","EFO_0007490"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for pain and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200933","canonicalSmiles":"C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21.[Br-].[Br-]","inchiKey":"WDEFPRUEZRUYNW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAFLUORENIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201349","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mylaxen"],"synonyms":["Hexafluorenium bromide","Hexaflurone bromide","Hexafluronium bromide","NSC-19477"],"crossReferences":{"PubChem":["144206765"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200974","canonicalSmiles":"CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"GVNWHCVWDRNXAZ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBINOXAMINE MALEATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL864","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbinoxamine maleate","Clistin","Davenol","Karbinal er"],"synonyms":["Carbinoxamine maleate","NSC-62362"],"crossReferences":{"DailyMed":["carbinoxamine%20maleate"],"PubChem":["144205889","170465237","26749308","93576626"],"chEBI":["31353"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007533","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 approved indications."}
{"id":"CHEMBL1201047","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.Cl","inchiKey":"UDUQHZSAAWGSPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201347","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leritine"],"synonyms":["Aldine","Anileridine dihydrochloride","Anileridine hcl","Anileridine hydrochloride","Anileridine hydrochloride cii","Apodol","Leritine dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201078","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIUM IN 111 CHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1447815","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Indiclor","Indium in 111 chloride"],"synonyms":["111indium trichloride","Indium (111 in) chloride","Indium (111in) chloride","Indium (111in) chloride injection","Indium chloride (111incl3)","Indium chloride in-111","Indium in 111 chloride","Indium in 111m chloride","Indium in-111 chloride","Indium in-111m chloride","Indium(iii) 111 chloride","Indium-111 chloride"],"crossReferences":{"DailyMed":["indium%20in-111%20chloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
{"id":"CHEMBL1201104","canonicalSmiles":"C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1","inchiKey":"ROAIXOJGRFKICW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHENAMINE HIPPURATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201270","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hiprex","Methenamine hippurate","Urex"],"synonyms":["Hexamine hippurate","Methenamine hippurate"],"crossReferences":{"DailyMed":["methenamine%20hippurate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for infection and urinary tract infection and has 1 investigational indication."}
{"id":"CHEMBL1201234","canonicalSmiles":"CNC(C)(C)Cc1ccccc1","inchiKey":"RXQCGGRTAILOIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENTERMINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mephentermine"],"crossReferences":{"PubChem":["11112475"],"Wikipedia":["Mephentermine"],"drugbank":["DB01365"],"chEBI":["6755"]},"childChemblIds":["CHEMBL1200996","CHEMBL3184799"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1201392","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"WXURHACBFYSXBI-GQKYHHCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMETHASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flucort","Flumetasone","Flumethasone","NSC-54702","U-10,974","U-10974"],"crossReferences":{"PubChem":["144204069","170465750","56422164","855624"],"Wikipedia":["Flumetasone"],"drugbank":["DB00663"],"chEBI":["34764"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201558","drugType":"Protein","blackBoxWarning":true,"name":"INTERFERON ALFA-2B","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intron a","Intron a hsa-free","Intron-A","Viraferon"],"synonyms":["Interferon alfa-2b","SCH 30500","SCH-30500"],"crossReferences":{"DailyMed":["interferon%20alfa-2b"],"DrugCentral":["5205"],"Wikipedia":["Interferon_alfa-2b"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0019471","EFO_0000558","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_0007147","EFO_0000565","EFO_0000339","EFO_1000956","EFO_0000389","EFO_0000182","EFO_0000673","EFO_0001668","EFO_0003047","EFO_0000616","EFO_0002618","MONDO_0004658","MONDO_0024503","MONDO_0008170","EFO_0000349","EFO_0004197","MONDO_0044881","MONDO_0008315","EFO_0004239","EFO_0009708","EFO_0000311","MONDO_0002691","EFO_0001422","EFO_0004220","EFO_0007306","MONDO_0100096","MONDO_0000544","EFO_0000764","EFO_0000574","MONDO_0002367","EFO_1001051","EFO_0001378","MONDO_0018906"],"count":39},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 9 approved and 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201785","canonicalSmiles":"CCCCCCOC(=O)CCC(=O)CN.Cl","inchiKey":"LZYXPFZBAZTOCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMINOLEVULINATE HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201784","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cysview kit","Hexvix"],"synonyms":["Cysview","Hexaminolevulinate hcl","Hexaminolevulinate hydrochloride","Hexyl aminolevulinate hcl","P-1026","P-1206"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for carcinoma and has 1 investigational indication."}
{"id":"CHEMBL120563","canonicalSmiles":"CN(C)C(=S)SSC(=S)N(C)C","inchiKey":"KUAZQDVKQLNFPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rezifilm"],"synonyms":["NSC-1771","NSC-49512","NSC-59637","NSC-622696","SQ 1489","SQ-1489","Thiram"],"crossReferences":{"PubChem":["11532980","144204701","144208767","144211419","170465664","17389717","26747381","26753057","490901","68535"],"drugbank":["DB13245"],"chEBI":["9495"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1230314","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O","inchiKey":"AJIPIJNNOJSSQC-NYLIRDPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTETROL","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["15.alpha.-hydroxyestriol","E-4","E4","Estetrol","Estetrol (anhydrous)","Estetrol anhydrous"],"crossReferences":{"drugbank":["DB12235"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","HP_0005184","MONDO_0100096","EFO_0000673","MONDO_0007254","EFO_0003922","EFO_0002950"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for pregnancy and has 5 investigational indications."}
{"id":"CHEMBL1231859","canonicalSmiles":"NC(=O)c1cncc([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"UINNILASBHZOTM-KMXXXSRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235122","canonicalSmiles":"C[C@]12C[C@@]34CCC(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2","inchiKey":"XADCWKSMHQPTGH-OFBLZTNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08366"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235161","canonicalSmiles":"C[N+](C)(C)CCOP(=O)(O)O","inchiKey":"YHHSONZFOIEMCP-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOCHOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphocholine"],"crossReferences":{"drugbank":["DB03945"],"chEBI":["18132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14","canonicalSmiles":"C[N+](C)(C)CCOC(N)=O.[Cl-]","inchiKey":"AIXAANGOTKPUOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBACHOL","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL965","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbachol","Carbastat","Doryl","Miostat"],"synonyms":["Carbachol","Carbachol chloride","Carbacholine Chloride","Carbacholine chloride","Carbamoylcholine chloride","NSC-32865"],"crossReferences":{"PubChem":["144205582","170464972","26747465","50105987","56463323"],"Wikipedia":["Carbachol"],"chEBI":["3385"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["MONDO_0001330","MONDO_0005129","EFO_0000516","HP_0000616"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1421","canonicalSmiles":"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1","inchiKey":"ZBNZXTGUTAYRHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASATINIB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"crossReferences":{"DailyMed":["dasatinib"],"PubChem":["103905543","124893650","124893651","124893652","144206289","164339436","170465390","50100097","50125840"],"Wikipedia":["Dasatinib"],"drugbank":["DB01254"],"chEBI":["49375"]},"linkedTargets":{"rows":["ENSG00000113721","ENSG00000142627","ENSG00000157404","ENSG00000010810","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000097007","ENSG00000186716","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":15},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0003869","EFO_0000756","EFO_1000657","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1001935","EFO_0000339","EFO_0000588","EFO_1000956","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0003884","EFO_0002918","EFO_1000785","EFO_0000198","EFO_0009441","MONDO_0001852","EFO_0002618","MONDO_0019465","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0002429","EFO_0005221","MONDO_0008315","EFO_1000026","GO_0007568","MONDO_0019474","EFO_1000654","MONDO_0100096","EFO_0003032","MONDO_0019472","EFO_0000574","EFO_1001051","EFO_0001378","EFO_1000550","EFO_1002001","MONDO_0019471","MONDO_0100342","MONDO_0003175","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_1000475","EFO_0000255","EFO_0000708","MONDO_0021063","EFO_1001469","MONDO_0003541","MONDO_0002087","EFO_0000305","EFO_1001480","MONDO_0002158","EFO_1000044","MONDO_0044743","EFO_0000770","EFO_0004289","EFO_0000196","EFO_0000673","EFO_1001993","EFO_0000183","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0006859","EFO_0005774","MONDO_0019457","Orphanet_44890","EFO_0000403","MONDO_0016586","MONDO_0000870","EFO_0000222","MONDO_0019469","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000095","MONDO_0011962","EFO_1001936","EFO_0000702","EFO_0000191","MONDO_0004975","MONDO_0018906","EFO_0003833","MONDO_0024880","EFO_0000519","EFO_0000181","MONDO_0004643"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 7 approved and 70 investigational indications."}
{"id":"CHEMBL1503","canonicalSmiles":"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1","inchiKey":"SUBDBMMJDZJVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEPRAZOLE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antra","Losec","Losec mups","Mezzopram","Mopral","Omeprazole","Omeran","Prilosec","Zanprol"],"synonyms":["H 168/68","H-168/68","NSC-751450","NSC-759192","Omeprazole"],"crossReferences":{"DailyMed":["omeprazole","omeprazole%20magnesium"],"PubChem":["104171331","11112840","124882676","124882677","144204237","144207707","170465443","174007234","26751452","26751453","50103932","56422106","855576"],"TG-GATEs":["12"],"Wikipedia":["Omeprazole"],"drugbank":["DB00338"],"chEBI":["77260"]},"childChemblIds":["CHEMBL2105294","CHEMBL1567328"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","EFO_0000729","HP_0002239","HP_0012735","EFO_0004274","HP_0003073","EFO_1001951","EFO_0000544","Orphanet_98869","EFO_0000676","HP_0003419","MONDO_0015277","EFO_1000961","HP_0001601","EFO_0000400","EFO_1001250","EFO_0002618","EFO_1000874","EFO_0003756","HP_0012532","EFO_0000180","EFO_0004607","EFO_0007549","EFO_0000384","MONDO_0008315","MONDO_0003523","MONDO_0001684","EFO_0004239","EFO_0004232","EFO_0000546","MP_0001914","EFO_0009130","EFO_0005741","EFO_0000574","EFO_0000341","EFO_0000516","EFO_0003767","HP_0100633","EFO_1001095","EFO_0005672","EFO_1000172","EFO_0004234","EFO_0000768","MONDO_0007254","Orphanet_586","MONDO_0043839","EFO_0000274","EFO_0000305","EFO_0003948","HP_0004398","MONDO_0001056","Orphanet_68380","EFO_0009462","MONDO_0004247","EFO_0004272","EFO_0007231","EFO_0003047","EFO_0002617","EFO_0000616","EFO_0000280","EFO_0000685","EFO_0006859","EFO_0001645","EFO_0003898","EFO_0003929","EFO_0007512","EFO_0003843","EFO_1001355","EFO_0000311","EFO_0008533","EFO_0009784","EFO_0009454","EFO_0004220","MONDO_0005147","EFO_0000764","MONDO_0004975","EFO_0000191","EFO_0000199","EFO_0005611","MONDO_0005148","MONDO_0005178","EFO_0000181","MONDO_0024475"],"count":83},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 7 approved and 62 investigational indications."}
{"id":"CHEMBL1515611","canonicalSmiles":"CC(C)C(Br)C(=O)NC(N)=O","inchiKey":"CMCCHHWTTBEZNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMISOVALUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bromural"],"synonyms":[".alpha.-bromisovalerylurea","2-bromo-3-methylbutyrylurea","Bromisoval","Bromisovalum","Bromovaluree","Bromvalerylurea","Bromvaletone","Brovarin","Calmotin","Dagrabromyl","Dibroluur","Dormigene","Upiol","Uvaleral"],"crossReferences":{"PubChem":["144205368","170465828","29216126"],"Wikipedia":["Bromisoval"],"drugbank":["DB13370"],"chEBI":["77043"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15571","canonicalSmiles":"c1nc[nH]n1","inchiKey":"NSPMIYGKQJPBQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2,4-TRIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,4-Triazole","1H-1,2,4-Triazole","4H-[1,2,4]Triazole"],"crossReferences":{"PubChem":["144210433"],"Wikipedia":["1,2,4-Triazole"],"drugbank":["DB03594"],"chEBI":["46077"]},"childChemblIds":["CHEMBL1377189"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1567463","canonicalSmiles":"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO","inchiKey":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE ALFOSCERATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-glycerylphosphorylcholine","Choline alfoscerate","Choline alphoscerate","Choline glycerophosphate","Gliatilin","Glycerophosphocholine","L-alpha-glycerylphosphorylcholine"],"crossReferences":{"PubChem":["855725"],"Wikipedia":["Alpha-GPC"],"drugbank":["DB04660"],"chEBI":["16870"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1592","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O","inchiKey":"JSDRRTOADPPCHY-HSQYWUDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINAPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C09AA06","CI-906","Quinapril"],"crossReferences":{"DailyMed":["quinapril%20hydrochloride"],"Wikipedia":["Quinapril"],"drugbank":["DB00881"],"chEBI":["8713"]},"childChemblIds":["CHEMBL1201011"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000712","EFO_0001645","EFO_0000319","EFO_0000400","EFO_1002048","EFO_0000537","MONDO_0001299"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 6 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1625750","canonicalSmiles":"Cc1ccc(S(=O)(=O)NCl)cc1","inchiKey":"NXTVQNIVUKXOIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMINE-T","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloramine-t"],"crossReferences":{"drugbank":["DB14708"],"chEBI":["53782"]},"childChemblIds":["CHEMBL1591636","CHEMBL1697734","CHEMBL4303314","CHEMBL3186336"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1699","canonicalSmiles":"CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl","inchiKey":"LDDHMLJTFXJGPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEMANTINE HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL807","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akatinol","Ebixa","Marixino","Memantine","Memantine hydrochloride","Namenda","Namenda xr","Nemdatine","Valios"],"synonyms":["Acrescent","Auxura","Balaxur","FP-01","Memantine accord","Memantine hcl","Memantine hydrochloride","Memantine lek","Memantine merz","Memantine mylan","Memantine ratiopharm","Memary","NSC-102290","SUN-Y7017"],"crossReferences":{"DailyMed":["memantine%20hydrochloride"],"PubChem":["26747595","50106707","50106708","57260151"],"chEBI":["64323"]},"linkedTargets":{"rows":["ENSG00000161509","ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003888","Orphanet_282","Orphanet_232","HP_0000726","EFO_1001465","EFO_0003758","EFO_0003757","EFO_0009267","EFO_0020000","EFO_1001801","MONDO_0004975","EFO_0000326","EFO_1001488","EFO_0007328","EFO_0004699","MONDO_0004976","MONDO_0004681","MONDO_0024880","EFO_0003833"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for dementia and alzheimer disease and has 12 investigational indications."}
{"id":"CHEMBL1700","canonicalSmiles":"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl","inchiKey":"VIDRYROWYFWGSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOTALOL HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL471","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-cardone","Betapace","Betapace af","Sorine","Sotacor","Sotalex","Sotalol hydrochloride","Sotylize"],"synonyms":["DL-MJ-1999","Darob","MJ 1999","MJ-1999","NSC-337251","NSC-760358","Sotalol hcl","Sotalol hydrochloride"],"crossReferences":{"DailyMed":["sotalol%20hydrochloride"],"PubChem":["144204819","26719708","46500431","50106953"],"chEBI":["9207"]},"linkedTargets":{"rows":["ENSG00000055118","ENSG00000169252","ENSG00000043591"],"count":3},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144","HP_0004308"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for ventricular arrhythmia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL170179","canonicalSmiles":"CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHADYL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACSCN-9601","Acemethadone","Acetylmethadol","Alphacetylmethadol","IDS-NA-004","Methadyl acetate","NIH-2953"],"crossReferences":{"drugbank":["DB01433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1705709","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FEREDETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sytron"],"synonyms":["Edetic acid sodium iron salt","Edta ferric sodium salt","Edta iron(iii) sodium salt","Edta, iron (iii) sodium","Ferrazone","Ferric sodium edetate","Ferrostrane","NSC-5237","Sodium feredetate","Sodium iron edta","Sodium ironedetate","Sybron"],"crossReferences":{"DrugCentral":["4709"],"PubChem":["144205670","144209121","144213753","170464680","26757848"],"chEBI":["78292"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL172513","canonicalSmiles":"C[N+](C)(C)CC(O)CC(=O)[O-]","inchiKey":"PHIQHXFUZVPYII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARNITINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carnitine","Carnitine chloride","Carnitine dl-form","NSC-757390","NSC-759132"],"crossReferences":{"Wikipedia":["Carnitine"],"chEBI":["17126"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1742992","drugType":"Antibody","blackBoxWarning":true,"name":"BLINATUMOMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Blinatumomab","MEDI-538","MT-103"],"crossReferences":{"DailyMed":["blinatumomab"],"DrugCentral":["4915"]},"linkedTargets":{"rows":["ENSG00000167286","ENSG00000177455","ENSG00000198851","ENSG00000160654"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000873","EFO_0000220","EFO_0001642","EFO_0000403","EFO_1001946","EFO_0000209","EFO_0005952","MONDO_0003541","EFO_0000565","MONDO_0020511","EFO_1001935","EFO_0000095","EFO_0000574","EFO_0001378","MONDO_0020743","EFO_0000094","MONDO_0002083"],"count":18},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for neoplasm and acute lymphoblastic leukemia and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1788399","drugType":"Small molecule","blackBoxWarning":false,"name":"COPPER OLEINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Copper oleinate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1877495","canonicalSmiles":"CC(NNC(=O)c1ccccc1)c1ccccc1","inchiKey":"BEWNZPMDJIGBED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENMOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benmoxin","Mebamoxine"],"crossReferences":{"PubChem":["144205441","29216229"],"drugbank":["DB09246"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1882461","canonicalSmiles":"C[N+]1(C)CCCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"UHUMRJKDOOEQIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevonium","Bevonium cation","Bevonium ion"],"crossReferences":{"PubChem":["50112676"],"drugbank":["DB13542"]},"childChemblIds":["CHEMBL2106080"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190170","canonicalSmiles":"CC(C)c1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"OQCFORGSZJSAEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07871"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19215","canonicalSmiles":"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21","inchiKey":"WZHJKEUHNJHDLS-QTGUNEKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METERGOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Liserdol"],"synonyms":["FI 6337","FI-6337","MCE","Metergoline","NSC-755878"],"crossReferences":{"PubChem":["104171342","124882907","124882908","144204359","170466571","26751517","26751518","50104076","50104077","50104078","56422452","85231339","855801","90341228"],"Wikipedia":["Metergoline"],"drugbank":["DB13520"],"chEBI":["64216"]},"childChemblIds":["CHEMBL1276418"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2021422","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1OCOP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"LWYLQNWMSGFCOZ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSPROPOFOL DISODIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201766","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquavan","Lusedra"],"synonyms":["Fospropofol disodium","Fospropofol disodium salt","Fospropofol sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and has 1 investigational indication."}
{"id":"CHEMBL2104482","canonicalSmiles":"O=Cc1c(O)cccc1OCc1ccc(C(=O)O)cc1","inchiKey":"XEDONBRPTABQFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCARESOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["589-C","589C","Tucaresol"],"crossReferences":{"drugbank":["DB13027"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104992","canonicalSmiles":"CS(=O)(=O)O.Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"BHECXGHXWKHZOY-DXPOFMJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESTIPITANT MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL522987","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-597588B","GW-597599B","GW597588B","GW597599B","Vestipitant mesilate","Vestipitant mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105199","canonicalSmiles":"O=C(c1ccccn1)c1cnn2c(-c3ccncc3)ccnc12","inchiKey":"OQJFBUOFGHPMSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCINAPLON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL 273,547","CL-273547","Ocinaplon"],"crossReferences":{"drugbank":["DB06529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105458","canonicalSmiles":"CN1CCC(N(Cc2cccs2)c2ccccc2)CC1","inchiKey":"KLOHYVOVXOUKQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THENALIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hematological toxicity"],"year":1960},"tradeNames":[],"synonyms":["Thenaldine","Thenalidine","Thenophenopiperidine"],"crossReferences":{"PubChem":["144206868"],"drugbank":["DB04826"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pruritus and allergic disease. It was withdrawn in United States  in 1960 due to Hematological toxicity."}
{"id":"CHEMBL2106274","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5","inchiKey":"LNNWVNGFPYWNQE-GMIGKAJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-deoxy-7,8-dihydromorphine","Deoxydihydromorphine d","Desomorphine","Dihydrodeoxymorphine","Dihydrodesoxymorphine d","IDS-ND-002","Krokodil","Permonid"],"crossReferences":{"drugbank":["DB01531"]},"childChemblIds":["CHEMBL3228684"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108063","drugType":"Antibody","blackBoxWarning":false,"name":"ZANOLIMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Humax-cd4"],"synonyms":["HuMax-CD4","MDX-016","Zanolimumab"],"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002913","EFO_0000574","EFO_1001051","EFO_1000785"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108313","drugType":"Protein","blackBoxWarning":false,"name":"CONBERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Conbercept","KH-902"],"linkedTargets":{"rows":["ENSG00000150630","ENSG00000119630","ENSG00000112715","ENSG00000173511"],"count":4},"linkedDiseases":{"rows":["EFO_1000880","EFO_0004683","EFO_0001365","EFO_0004207","EFO_1001157","Orphanet_790","EFO_0009322","EFO_0005773","EFO_0009321"],"count":9},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108559","drugType":"Unknown","blackBoxWarning":false,"name":"SENNOSIDES","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gentle nature","Glysennid"],"synonyms":["Calcium sennoside","Calcium sennosides","Colonorm","Nytilax","Pursennid","Pursennide","Sennoside","Sennoside ca","Sennosides","Sennosides (as calcium)"],"crossReferences":{"DrugCentral":["4307"]},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108775","drugType":"Unknown","blackBoxWarning":false,"name":"PODOPHYLLUM RESIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Podoph","Podoph co"],"synonyms":["Podophyllin","Podophyllum resin"],"crossReferences":{"DrugCentral":["5114"]},"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108818","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 LABETUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cea-cide"],"synonyms":["90Y-HMN-14","Labetuzumab 90y","S9S0Y-HMN-14","Yttrium y 90 labetuzumab","Yttrium y-90 labetuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108833","drugType":"Protein","blackBoxWarning":false,"name":"AVOTERMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avotermin","Human tgfb3","Juvista"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109058","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"EDIFOLIGIDE SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG-T003","CGT-003","CGT003","E2f duplex decoy","E2f duplex decoy (trivial name)","Edifoligide sodium"],"linkedTargets":{"rows":["ENSG00000205250","ENSG00000133740","ENSG00000165891","ENSG00000169016","ENSG00000129173","ENSG00000112242","ENSG00000101412","ENSG00000007968"],"count":8},"linkedDiseases":{"rows":["EFO_0001645"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109168","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN 40","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gentran 40"],"synonyms":["Dextran 40","LMD","LMWD"],"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110962","canonicalSmiles":"CC(Cc1ccccc1)NCCCCl","inchiKey":"XXVROGAVTTXONC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEFENOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mefenorex"],"crossReferences":{"PubChem":["170465601"],"drugbank":["DB13852"]},"childChemblIds":["CHEMBL2106838"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2147475","canonicalSmiles":"COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OC[C@H](OP(=O)(O)O)C1CC1","inchiKey":"YDTUJCNTIMWHPJ-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-830216","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-830216","Bms-830216"],"crossReferences":{"drugbank":["DB14787"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL22077","canonicalSmiles":"CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12","inchiKey":"MFZWMTSUNYWVBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYCANTHONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hycanthone","NSC-134434","NSC-142982","WIN 24,933","WIN-24933"],"crossReferences":{"PubChem":["104171314","11112528","11533028","144204082","170466535","26748752","26748753","423107","50122910","56424135"],"Wikipedia":["Hycanthone"],"drugbank":["DB14061"],"chEBI":["52768"]},"childChemblIds":["CHEMBL1983709"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221722","canonicalSmiles":"NC(=O)c1nc(F)cnc1O","inchiKey":"ZCGNOVWYSGBHAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAVIPIRAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avigan","Favipiravir","T-705"],"crossReferences":{"drugbank":["DB12466"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL224060","canonicalSmiles":"Cn1nnc2ccc([C@H](c3ccc(Cl)cc3)n3cncn3)cc21","inchiKey":"XLMPPFTZALNBFS-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rivizor"],"synonyms":["R 83842","R-83842","R-83942","Vorozole"],"crossReferences":{"Wikipedia":["Vorozole"],"drugbank":["DB13767"]},"childChemblIds":["CHEMBL1668497"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL225072","canonicalSmiles":"Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1","inchiKey":"WBXPDJSOTKVWSJ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMETREXED","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"crossReferences":{"DailyMed":["pemetrexed%20disodium"],"PubChem":["124893263","124950689","525786"],"Wikipedia":["Pemetrexed"],"drugbank":["DB00642"],"chEBI":["63616"]},"childChemblIds":["CHEMBL2360464","CHEMBL3989962"],"linkedTargets":{"rows":["ENSG00000176890","ENSG00000228716","ENSG00000159131"],"count":3},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0000637","EFO_0000365","EFO_0001075","EFO_0000571","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000308","EFO_0000228","EFO_1001951","EFO_0000178","Orphanet_178","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0002618","MONDO_0002108","MONDO_0008170","EFO_1000157","EFO_0002939","MONDO_0008315","EFO_0009708","MONDO_0002691","EFO_0005567","EFO_1000576","EFO_0004284","EFO_0000233","EFO_0000574","EFO_0006544","MONDO_0100342","EFO_1001901","MONDO_0021117","MONDO_0015686","MONDO_0044887","MONDO_0004192","MONDO_0007254","EFO_1001012","EFO_0000708","EFO_0004252","MONDO_0002087","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0003860","EFO_0000770","EFO_0000707","EFO_0002617","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","Orphanet_59305","EFO_0000403","MONDO_0007576","EFO_0000313","MONDO_0000521","EFO_0003060","EFO_1000124","EFO_0000311","EFO_0003863","EFO_1000581","MONDO_0056806","MONDO_0002586","EFO_0006861","MONDO_0011962","EFO_0000702","EFO_0004142","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0003050"],"count":79},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 5 approved and 75 investigational indications."}
{"id":"CHEMBL228224","canonicalSmiles":"Cc1n[nH]cc1-c1ccc(CCN)cc1","inchiKey":"ILTOXASLQDKYJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228224","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364656","drugType":"Protein","blackBoxWarning":false,"name":"TOPSALYSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX-302","PRX302","Topsalysin"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2408045","canonicalSmiles":"CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1","inchiKey":"DFJSJLGUIXFDJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8931","AZD8931","Azd-8931","Sapitinib"],"crossReferences":{"PubChem":["174006599"],"drugbank":["DB12183"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001480","EFO_0000365","MONDO_0007254","MONDO_0024880","EFO_0003060","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL259728","canonicalSmiles":"CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC","inchiKey":"CFRPSFYHXJZSBI-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITENPYRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205895","170466859"],"drugbank":["DB11438"],"chEBI":["39170"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266800","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=NCCO3)cc2)on1","inchiKey":"IWZDYGHUSXWPPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL266800","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08720"],"chEBI":["10028"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267476","canonicalSmiles":"CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)O","inchiKey":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINOLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9,12-linoleic acid","C18:2 (n-6)","Emersol 315","FEMA NO. 3380, LINOLEIC ACID-","Linoleate","Linoleic acid","Linolic acid","NSC-281243","Octadeca-9,12-Dienoic Acid","Polylin 515","Ronacare asc 3","Unifac 6550"],"crossReferences":{"PubChem":["144204618","144209369","144213397","17388946","26752888"],"Wikipedia":["Linoleic_acid"],"drugbank":["DB14104"],"chEBI":["17351"]},"childChemblIds":["CHEMBL3122088","CHEMBL571449"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL279865","canonicalSmiles":"CCC(=O)OC1(c2ccccc2)CCN(C)CC1","inchiKey":"BCQMRZRAWHNSBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL279865","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Desmethylprodine"],"drugbank":["DB01478"]},"childChemblIds":["CHEMBL3188300"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280074","canonicalSmiles":"Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21","inchiKey":"GTVPOLSIJWJJNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOMOUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olomoucine","Olomucine"],"crossReferences":{"PubChem":["103905126","11111567","11114014","124880964","124880967","124880968","26752151","26752152","26752153","50104796","50104797","511554","85231165","90340618"],"drugbank":["DB02116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137341","drugType":"Cell","blackBoxWarning":false,"name":"SEVIPROTIMUT-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["POL-103A","Seviprotimut l","Seviprotimut-l"],"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137344","drugType":"Enzyme","blackBoxWarning":false,"name":"LATIGLUTENASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALV-003","ALV003","Latiglutenase"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL313833","canonicalSmiles":"NC1CC1c1ccccc1","inchiKey":"AELCINSCMGFISI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANYLCYPROMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006850","90340789"],"drugbank":["DB00752"]},"childChemblIds":["CHEMBL542118"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL314691","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O","inchiKey":"VYCMAAOURFJIHD-PJNXIOHISA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL314691","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12054"],"chEBI":["2965"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184986","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].O.O.[Zn+2]","inchiKey":"BEAZKUGSCHFXIQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC ACETATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200928","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galzin","Wilzin"],"synonyms":["Zinc acetate","Zinci acetas"],"crossReferences":{"PubChem":["144208062"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for exanthem and movement disorder."}
{"id":"CHEMBL3545109","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-502","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-502","Arry-502"],"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545248","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-7423","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ds-7423"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["MONDO_0011962","EFO_1001951"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707214","canonicalSmiles":"O=C(ON1CCOCC1)c1ccccc1O","inchiKey":"BMOINOKSLLYQQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHOLINE SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morpholine salicylate"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707224","canonicalSmiles":"CCOC(=O)C[N+]1(C)CC[C@@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)C1","inchiKey":"SEVCTUCCZYBJER-BSJAROSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFPIRONIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bbi-4000 ion","Sofpironium cation"],"childChemblIds":["CHEMBL3707223"],"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["HP_0000975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707347","canonicalSmiles":"CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(=O)O","inchiKey":"YYBOLPLTQDKXPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERINURAD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RDEA-3170","RDEA3170","Verinurad"],"crossReferences":{"drugbank":["DB11873"]},"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["EFO_0009104","EFO_0003144","EFO_0004274","EFO_0003884"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3780740","canonicalSmiles":"COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1.O=S(=O)(O)O","inchiKey":"IFBYQAMJTBOBHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBEGLITAZONE SULFATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3585580","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKD-501","Ckd-501","Lobeglitazone sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3786896","canonicalSmiles":"CCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1","inchiKey":"YUHNXUAATAMVKD-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8165","AZD8165","Azd 8165","Azd-8165","Azd8165"],"crossReferences":{"drugbank":["DB15132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989451","canonicalSmiles":"CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(OC(C)=O)ccc5c4[C@@]12CCN(C)[C@@H]3C5","inchiKey":"LFYBMMHFJIAKFE-PMEKXCSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7.alpha.-etorphine 3-acetate","Acetorphine","Acetylpropylorvinol","IDS-NA-001"],"crossReferences":{"drugbank":["DB01469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3990004","drugType":"Unknown","blackBoxWarning":false,"name":"BIROPEPIMUT-S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biropepimut s","Biropepimut-s","GL-0817","MAGE-A3 Trojan Peptide Vaccine"],"linkedTargets":{"rows":["ENSG00000221867"],"count":1},"linkedDiseases":{"rows":["EFO_0000199"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL404150","canonicalSmiles":"NCCc1ccc(O)c(C2CCCCC2)c1","inchiKey":"DOCCSEDGBYCYLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404150","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07345"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4088896","canonicalSmiles":"C[C@H](CN1CCOCC1)n1/c(=N\\C(N)=O)[nH]c2cc(/C=C3\\c4ccccc4COc4cc(F)ccc43)ccc21","inchiKey":"YPCLDHGBEKZGEB-RUDKWAFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4088896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42055","canonicalSmiles":"OCCN1CCN(CC/C=C2\\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"NJMYODHXAKYRHW-BLLMUTORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-FLUPENTIXOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-flupenthixol","E-flupenthixol","E-flupentixol","Flupenthixol","Flupentixol, (e)-","Flupentixole","Trans-flupenthixol","Trans-flupentixol"],"crossReferences":{"PubChem":["11111164","11111165"],"Wikipedia":["Flupentixol"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4283439","canonicalSmiles":"CCOc1ccc2c(c1)[C@]1(CC[C@H](OCCN3CCOCC3)CC1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC","inchiKey":"QKXJWFOKVQWEDZ-VCCCEUOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4283439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14923"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4291143","canonicalSmiles":"Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C(=O)N3CCc4cc(C(=O)Nc5c(C)cccc5F)sc4-c4ccccc43)cc2)c1","inchiKey":"VTCJNYICQADBJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PC-786","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PC-786","PC786","Pc-786","Pc786"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297303","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C1CCCC1)NC(=O)O[C@@H]1CCC[C@H]1CCCCCn1c(nc3cc(OC)ccc3c1=O)O2)C(=O)NS(=O)(=O)C1(C)CC1","inchiKey":"HMYVZDWJFQOHCD-XEZGQWAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2748","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK2748","Mk-2748"],"crossReferences":{"drugbank":["DB15371"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297492","canonicalSmiles":"CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1","inchiKey":"LFMPVTVPXHNXOT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2245035","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2245035","GSK2245035","Gsk-2245035","Gsk2245035"],"linkedTargets":{"rows":["ENSG00000196664"],"count":1},"linkedDiseases":{"rows":["EFO_0010638","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297561","drugType":"Unknown","blackBoxWarning":false,"name":"EPI-589","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPI-589","Epi-589"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297688","drugType":"Unknown","blackBoxWarning":false,"name":"ADU-S100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADU-S100","Adu s100","Adu-s100","CDN AGONIST ADU-S100","MIW815","MW-815","Miw815"],"linkedTargets":{"rows":["ENSG00000184584"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000574"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297890","drugType":"Unknown","blackBoxWarning":false,"name":"ARC-19499","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC19499","Arc-19499","Arc19499","BAX-499","BAX499"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297916","drugType":"Unknown","blackBoxWarning":false,"name":"BNC-105P","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bnc-105p","Bnc105p"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297968","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-3174998","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3174998","GSK3174998","Gsk 3174998","Gsk-3174998","Gsk3174998"],"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001378"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL454801","canonicalSmiles":"COC1=C(OC)C(=O)C(C/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)=C(C)C1=O","inchiKey":"ACTIUHUUMQJHFO-UPTCCGCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UBIDECARENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["API 31510","API-31510","Adelir","Aqua q10","Bio-quinone q10","Bpm-31510","Bpm31510","Co-enzyme q10","Coenzyme q-10","Coenzyme q-199","Coenzyme q10","Coq10","NSC-140665","NSC-140865","Oristar ubq","Puresorb q 40","Ubidecarenone","Ubidecarenone for system suitability","Ubiquinone","Ubiquinone 10","Ubiquinone 50","Ubiquinone q10","Ubiquinone-10","Unispheres q 10","Vitamin q"],"crossReferences":{"PubChem":["144205213","29215368"],"Wikipedia":["Coenzyme_Q10"],"drugbank":["DB09270"],"chEBI":["46245"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 33 investigational indications."}
{"id":"CHEMBL458616","canonicalSmiles":"OCCCCCCO","inchiKey":"XXMIOPMDWAUFGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,6-HEXANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,6-Hexanediol"],"crossReferences":{"PubChem":["144207648"],"Wikipedia":["1,6-Hexanediol"],"drugbank":["DB02210"],"chEBI":["43078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594253","canonicalSmiles":"Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"ZVPYVZMKBQYKQG-ZVWHLABXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVAVOTINIB CITRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3979920","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mivavotinib citrate","TAK-659","Tak 659","Tak-659"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0001075","MONDO_0044889","EFO_0000403","EFO_0000574","EFO_0000222","MONDO_0018906","EFO_0005952"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4594329","drugType":"Enzyme","blackBoxWarning":false,"name":"CIPAGLUCOSIDASE ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT GAA","ATB-200","ATB200","Cipaglucosidase alfa"],"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594429","canonicalSmiles":"CC(C)n1c(=O)n(C)c2cnc3cc(F)c(-c4ccc(OCCCN5CCCCC5)nc4)cc3c21","inchiKey":"VQSZIPCGAGVRRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1390","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-1390","AZD1390","Azd-1390","Azd1390"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594456","drugType":"Antibody","blackBoxWarning":false,"name":"CADONILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-104","AK104","Ak-104","Ak104","Cadonilimab"],"linkedTargets":{"rows":["ENSG00000163599","ENSG00000188389"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001061","MONDO_0002974","EFO_0000756","MONDO_0008903","EFO_0000349","EFO_0000182","EFO_0004252","EFO_0003060","EFO_0000311"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4594507","drugType":"Unknown","blackBoxWarning":false,"name":"TRANSCON CNP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Transcon cnp","Transcon cnp-38"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594513","drugType":"Antibody","blackBoxWarning":false,"name":"SAMROTAMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-085","Abbv-085","Adc abbv-085","Antibody-drug conjugate abbv-085","PR-1498487 PAB-MMAE","Samrotamab vedotin"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594546","drugType":"Antibody","blackBoxWarning":false,"name":"TELAZORLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 830","GBR-830","GBR830","Gbr 830","ISB 830","ISB-830","Telazorlimab"],"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0000274"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594555","drugType":"Unknown","blackBoxWarning":false,"name":"DEXTRAN SULFATE SODIUM (5000 MW)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran sulfate sodium (5000 mw)","Dextran sulfate sodium (mw 5000)","Ibsolvmir"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650267","drugType":"Gene","blackBoxWarning":false,"name":"DABOCEMAGENE AUTOFICEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dabocemagene autoficel","FCX-007"],"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650360","canonicalSmiles":"COc1ccc(-c2c(-c3ccc(C#N)c(F)c3)nc(N3CCC(N)CC3)n(C)c2=O)cc1F.O=S(=O)(O)c1ccccc1","inchiKey":"AWZCBGWZNHQCIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PULRODEMSTAT BESILATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4651180","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-90011","Cc-90011","Pulrodemstat besilate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4802153","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(C(=O)N[C@@H]1CCCNC1)O2","inchiKey":"LZYWLEPSQNXESC-KUHUBIRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SONLICROMANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kh-176","Sonlicromanol"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802201","drugType":"Small molecule","blackBoxWarning":false,"name":"DAVAMOTECAN PEGADEXAMER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CRLX 101","CRLX101","Crlx-101 drug substance","Crlx101","Davamotecan pegadexamer","IT101"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL48046","canonicalSmiles":"COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cccc(CN)c2)cc1","inchiKey":"XFKVLKLCLYJKNF-MZNJEOGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04424"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL487465","canonicalSmiles":"COCCOCCOCCOc1cccc(C2=N[C@@](C)(C(=O)O)CS2)c1O","inchiKey":"AWHIMFSHNAAMBM-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFERITAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fbs0701, spd602"],"synonyms":["Deferitazole","FBS-0701","FBS0701","SPD-602","SPD602"],"crossReferences":{"drugbank":["DB13120"]},"childChemblIds":["CHEMBL495105"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL493636","canonicalSmiles":"CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"GWBPFRGXNGPPMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFANITRAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-217299","NSC-77120","Sulfanitran"],"crossReferences":{"PubChem":["144204954","170466141","26748787"],"drugbank":["DB11463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494708","canonicalSmiles":"CCCCC/C=C/CC(C/C=C/CCCCC)(P(=O)(O)O)P(=O)(O)O","inchiKey":"PFKBXXKNHWTTCS-PHEQNACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BPH-798","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPH-798"],"crossReferences":{"drugbank":["DB08529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL503","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21","inchiKey":"PCZOHLXUXFIOCF-BXMDZJJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOVASTATIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Altoprev","Lovastatin","Mevacor","Mevinacor","Mevinacor 10","Mevinacor 40"],"synonyms":["6.alpha.-methylcompactin","C10AA02","L-154803","Lovastatin","MK-803","Mevinolin","Mevlor","Monacolin k","NSC-758662","Simvastatin impurity, lovastatin-","Sivlor"],"crossReferences":{"DailyMed":["lovastatin"],"PubChem":["144204439","144208673","144210588","170464913","17389841","26751557","496591","49732779","855905"],"Wikipedia":["Lovastatin"],"drugbank":["DB00227"],"chEBI":["40303"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","Orphanet_909","EFO_0000756","MONDO_0007254","EFO_0003876","Orphanet_778","EFO_0003914","HP_0100543","EFO_1001375","MONDO_0005180","EFO_0000712","MONDO_0004681","EFO_1000757","EFO_0004705","Orphanet_2745","EFO_0000685","Orphanet_46724","HP_0003124","MONDO_0008170","EFO_0001645","Orphanet_636","EFO_0000222","EFO_0000319","MONDO_0008315","Orphanet_309005","Orphanet_908","EFO_0002615","EFO_0000589","MP_0001845","MONDO_0021661","EFO_0000764","MONDO_0004979","EFO_0000341","EFO_1000860"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 6 approved and 27 investigational indications."}
{"id":"CHEMBL516023","canonicalSmiles":"NC(=O)c1cccc(Cn2c3c(c4cccc(C(=O)O)c42)CCCCC3)c1","inchiKey":"GKBQRPKZHUFGOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL516023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL551064","canonicalSmiles":"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1","inchiKey":"USVCWSAJUAARAL-MEMLXQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AEW-541","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEW 541","Aew-541","NVP-AEW 541","NVP-AEW541"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL551561","canonicalSmiles":"CSC[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"WBPLMFVTQMIPLW-MFYTUXHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL551561","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL606258","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@H]2C)O[C@@H](C)[C@@H]1O","inchiKey":"RZPAKFUAFGMUPI-QESOVKLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEANDOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E704","Oleandomycin"],"crossReferences":{"Wikipedia":["Oleandomycin"],"drugbank":["DB11442"],"chEBI":["16869"]},"childChemblIds":["CHEMBL2105788"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL620","canonicalSmiles":"C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2","inchiKey":"HOOSGZJRQIVJSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIDINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clidinium","Clidinium cation","Clidinium ion"],"crossReferences":{"DailyMed":["clidinium%20bromide"]},"childChemblIds":["CHEMBL1200950"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL74","canonicalSmiles":"O=C([O-])c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)[O-])cc(=O)c34)cccc2o1.[Na+].[Na+]","inchiKey":"VLARUOGDXDTHEH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CROMOLYN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL428880","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerocrom","Allercrom","Aspire","Brol-eze","Catacrom","Clariteyes","Crolom","Cromogen","Cromogen e-breathe","Cromolux","Cromolyn sodium","Cromoptic","Cromosol","Cromosol optha","Cusilyn","Dominion pharma hayfever","Eye-crom","Gastrocrom","Glycavent","Gppe syncroner inha","Hay-crom","Intal","Intal 5","Lomudal","Lomusol","Murine","Nalcrom","Nasalcrom","Opticrom","Opticrom aq","Resiston one","Resiston treatment pack","Rynacrom","Rynacrom allergy","Rynacrom co","Steri-neb cromogen","Vivicrom","Vividrin","Viz-on"],"synonyms":["Astilyn","Cromoglicate sodium","Cromoglycic acid","Cromolyn","Cromolyn disodium salt","Cromolyn sodium","Disodium cromolyn","FPL-670","FPL.670","NSC-109500","Natrii cromoglicas","Sodium cromoglicate","Sodium cromoglycate","Sodium cromolyn"],"crossReferences":{"DailyMed":["cromolyn%20sodium"],"PubChem":["11112999","124882750","144204414","144212320","170464887","26747950","855804"],"Wikipedia":["Cromoglicic_acid"],"chEBI":["128458"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 approved and 2 investigational indications."}
{"id":"CHEMBL843","canonicalSmiles":"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SUFUKZSWUHZXAV-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROSIGLITAZONE MALEATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL121","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2010},"tradeNames":["Avandia","Rosiglitazone maleate"],"synonyms":["Avandia","BRL-49653","BRL-49653-C","BRL-49653C","NSC-717764","Rosiglitazone maleate","Rosiglitzazone maleate"],"crossReferences":{"DailyMed":["rosiglitazone%20maleate"],"PubChem":["144212684","49681563"],"chEBI":["8892"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0006859","HP_0002745","EFO_0002614","EFO_0000764","EFO_1001249","EFO_0000373","EFO_1001110","EFO_0000400","MONDO_0005148","EFO_0000691","EFO_1000158"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 10 investigational indications. It was withdrawn in European Union  in 2010 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL88712","canonicalSmiles":"O=C(O)[C@@H](c1ccc(OCc2ccc3ccccc3n2)cc1)C1CCCC1","inchiKey":"ZEYYDOLCHFETHQ-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELIFLAPON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY X 1005","BAY-X-005","BAY-X-1005","DG-031","Veliflapon"],"linkedTargets":{"rows":["ENSG00000132965"],"count":1},"linkedDiseases":{"rows":["EFO_0005672"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL908","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"WSPOMRSOLSGNFJ-AUWJEWJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROTHIXENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Taractan","Truxal"],"synonyms":["Chlorprothixene","N-714","N-714RO 4-0403","NSC-18720","RO 4-0403","RO-4-0403","RO-40403"],"crossReferences":{"PubChem":["26665646","29217891"],"Wikipedia":["Chlorprothixene"],"drugbank":["DB01239"],"chEBI":["50931"]},"childChemblIds":["CHEMBL1256658"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL96172","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1","inchiKey":"XOZIUKBZLSUILX-GIQCAXHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPOTHILONE D","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-desoxyepothilone b","12,13-desoxyepothilone b","12,13-desoxyepothilone b, cis","Desoxyepothilone b","Epothilone d","KOS-862","NSC-703147","R-1492","R1492"],"crossReferences":{"PubChem":["527930"],"drugbank":["DB01873"],"chEBI":["29579"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008903","MONDO_0007254","MONDO_0008315","EFO_1001951"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL99668","canonicalSmiles":"N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12","inchiKey":"XOKJUSAYZUAMGJ-WOUKDFQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOYOCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
